Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-07 14:03:18 - browse：89154

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： FDA advisory panel to debate high blood pressure devices

WSS

How the drug

Biogen nominates mother of director’s child to replace him on board

Senate panel passes drug pricing bills, but drops one PBM reform

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Timeline: Key moments in fight for gay rights

Can medical device makers keep up in the race to treat obesity?

explore

Wikipedia

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Health officials lay out plans to cope with respiratory virus season

Guidelines to prevent youth baseball injuries need more muscle

Abortion policy in the spotlight at Republican debate

Trump demands the U.S. pay no more for drugs than other countries … again

Roche's accidental data boosts hopes for anti

The cancer drug shortage isn’t new — and neither are the solutions

Mom launches Girl Scout troop for LGBTQ youth in Texas

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Can medical device makers keep up in the race to treat obesity?

Wikipedia

Novo: Oral version of Ozempic leads to 15% weight loss

The thinking behind the controversial eating disorder chatbot Tessa

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Republicans love RFK Jr. What's that tell us about health in 2024?

Timeline: Key moments in fight for gay rights

entertainment

knowledge

leisure time

focus